| Long name: |
CYLD Primary Polyclonal Antibody |
| Also known as: |
CYLD PAb |
| Category: |
Primary Antibodies |
| Conjugation: |
Unconjugated |
| Target Antigen: |
CYLD |
| Specificity: |
This is a highly specific antibody against CYLD |
| Modification(s): |
None |
| Modification site(s): |
Unmodified antibody |
| Clonality: |
Polyclonal antibody |
| Clone number: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
This antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human cylindromatosis 1 |
| Gene ID number: |
1540 |
| Tested Applications: |
IF(IHC-P), IHC-P, WB |
| Recommended dilutions: |
IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000) |
| Cross reactivity: |
Mouse, Rat, Human |
| Cross reactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Background of the target antigen: |
CYLD has deubiquitinating activity, CYLD is an autosomal dominant and highly tumor type-specific disorder, Cylindromas arise predominantly in hairy parts of the body with approximately 90% on the head and neck, The development of a confluent mass which may ulcerate or become infected has led to the designation ", The skin tumors show differentiation in the direction of hair structures, The tumors (known as cylindromas because of their characteristic microscopic architecture) are believed to arise from or recapitulate the appearance of the eccrine or apocrine cells of the skin that secrete sweat and scent respectively, hence the synonym trichoepithelioma, Defects in CYLD are the cause of familial cylindromatosis (CYLD) also known as turban tumor syndrome or dermal eccrine cylindromatosis, turban tumor syndrome" |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA |
| Synonym names: |
BRSS, CDMT, CYLD, CYLD1, CYLDI, CYLD_HUMAN, Deubiquitinating enzyme CYLD, EAC, EAC, HSPC057, KIAA0849, MFT, MFT1, SBS, TEM, USPL2, Ubiquitin carboxyl-terminal hydrolase CYLD, Ubiquitin thiolesterase CYLD, Ubiquitin-specic processing protease CYLD, cylindromatosis 1, cylindromatosis turban tumor syndrome, turban tumor syndrome, CDMT |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
CYLD |
| Short name: |
CYLD Antibody |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
CYLD (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
2584 |
| Gene: |
CYLD |
More about : CYLD |
| Long gene name: |
CYLD lysine 63 deubiquitinase |
| Synonyms gene: |
CYLD1 |
| Synonyms gene name: |
cylindromatosis (turban tumor syndrome) |
| Synonyms: |
KIAA0849 USPL2 |
| Synonyms name: |
ubiquitin specific peptidase like 2 |
| Locus: |
16q12, 1 |
| Discovery year: |
1996-12-17 |
| GenBank acession: |
AB020656 |
| Entrez gene record: |
1540 |
| Pubmed identfication: |
7493027 |
| Classification: |
Ubiquitin specific peptidases |
| Havana BLAST/BLAT: |
OTTHUMG00000173404 |
| Locus Specific Databases: |
LRG_491 |